Special Report: Countries, companies risk billions in race for coronavirus vaccine

Go back to Special Report: Countries, companies risk billions in race for coronavirus vaccine

Cantor Fitzgerald Reiterates Overweight Rating on Johnson & Johnson (JNJ) Following Court Decision

April 28, 2020 6:53 AM EDT

Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $168.00 price target on Johnson & Johnson (NYSE: JNJ) following the courts much-anticipated Daubert decision, which Chen thinks turned out favorably for the company. The judge decided that certain plaintiff expert witnesses did not present... More

Mizuho Securities Reiterates Buy Rating on Pfizer (PFE) Ahead of 1Q Report

April 27, 2020 6:44 AM EDT

Mizuho Securities analyst Vamil Divan reiterated a Buy rating and $42.00 price target on Pfizer (NYSE: PFE) ahead of the company's 1Q earnings report. The stock has had a nice recovery over the past month but remains down ~4.5% YTD. The company's is scheduled to report... More